Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

Ann Intern Med. 2021 Sep;174(9):1330-1332. doi: 10.7326/L21-0282. Epub 2021 Jun 15.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Viral / blood
  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / adverse effects*
  • COVID-19 Vaccines / immunology*
  • Female
  • Humans
  • Immunocompromised Host*
  • Male
  • Middle Aged
  • SARS-CoV-2 / immunology*
  • Transplant Recipients*

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines